IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden · Delayed Price · Currency is SEK 1.730
-0.010 (-0.57%)
Sep 22, 2026, 5:29 PM CET
IRLAB Therapeutics AB Market Cap
IRLAB Therapeutics AB has a market cap or net worth of 257.27 million as of September 22, 2026. Its market cap has decreased by -1.34% in one year.
Market Cap
257.27M
Enterprise Value
247.25M
Revenue
79.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.73
ChartMarket Cap Chart
Since February 28, 2017, IRLAB Therapeutics AB's market cap has decreased from 413.00M to 257.27M, a decrease of -37.71%. That is a compound annual growth rate of -4.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 257.27M | 53.75% |
| Dec 30, 2025 | 167.33M | -69.99% |
| Dec 30, 2024 | 557.59M | 43.33% |
| Dec 29, 2023 | 389.01M | -80.42% |
| Dec 30, 2022 | 1.99B | -12.75% |
| Dec 30, 2021 | 2.28B | 4.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mendus AB | 428.39M |
| Cantargia AB | 390.07M |
| Corline Biomedical AB | 371.09M |
| Intervacc AB | 344.22M |
| Sprint Bioscience AB | 311.27M |
| Isofol Medical AB | 237.16M |
| Xbrane Biopharma AB | 208.11M |
| Elicera Therapeutics AB | 185.86M |